Exact Mass: 360.0157798

Exact Mass Matches: 360.0157798

Found 22 metabolites which its exact mass value is equals to given mass value 360.0157798, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

fructose-6-phosphate pyruvate

6,7,8,9-tetrahydroxy-6-(hydroxymethyl)-2-oxo-1,3,5-trioxa-2lambda5-phosphaspiro[3.5]nonan-2-yl 2-oxopropaneperoxoate

C9H13O13P (360.00937780000004)


   

ZINC4390122

ZINC4390122

C14H11F3N2O2S2 (360.02140219999995)


   

1,4,7,10,13,16-hexathiacyclooctadecane

1,4,7,10,13,16-hexathiacyclooctadecane

C12H24S6 (360.02022239999997)


   

6-AMINO-2-(BENZO[D][1,3]DIOXOL-5-YLMETHYL)-4-BROMOISOINDOLIN-1-ONE

6-AMINO-2-(BENZO[D][1,3]DIOXOL-5-YLMETHYL)-4-BROMOISOINDOLIN-1-ONE

C16H13BrN2O3 (360.01094880000005)


   

2-(BETA-ANILINO)VINYL-3-ETHYL THIAZOLIUM IODIDE

2-(BETA-ANILINO)VINYL-3-ETHYL THIAZOLIUM IODIDE

C13H17IN2S (360.01571520000005)


   

METHACRYLOXYDIPHENYLANTIMONY

METHACRYLOXYDIPHENYLANTIMONY

C16H15O2Sb (360.011023)


   

1,5-Naphthalenedisulfonic acid tetrahydrate

1,5-Naphthalenedisulfonic acid tetrahydrate

C10H16O10S2 (360.0184876)


   

AMMONIUM MAGNESIUM SULFATE HEXAHYDRATE

AMMONIUM MAGNESIUM SULFATE HEXAHYDRATE

H20MgN2O14S2 (360.020644)


   

Methyl 4-O-benzoyl-6-bromo-6-deoxy-α-D-glucopyranoside

Methyl 4-O-benzoyl-6-bromo-6-deoxy-α-D-glucopyranoside

C14H17BrO6 (360.0208442)


   

Ethyl2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate

Ethyl2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate

C16H13BrN2O3 (360.01094880000005)


   

2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide

2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide

C14H14Cl2N2O3S (360.0102154)


   

4,5-Dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid

4,5-Dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid

C17H10Cl2N2O3 (360.006845)


   

1-(4-Chlorophenyl)-2-[[3-(3-methylphenyl)-1,2,4-thiadiazol-5-yl]thio]ethanone

1-(4-Chlorophenyl)-2-[[3-(3-methylphenyl)-1,2,4-thiadiazol-5-yl]thio]ethanone

C17H13ClN2OS2 (360.0157798)


   

4-Phosphonooxy-phenyl-methyl-[4-phosphonooxy]benzen

4-Phosphonooxy-phenyl-methyl-[4-phosphonooxy]benzen

C13H14O8P2 (360.0163904)


   

[5,6,7,8-Tetrahydroxy-8-(hydroxymethyl)-2-oxo-1,3,9-trioxa-2lambda5-phosphaspiro[3.5]nonan-2-yl] 2-oxopropaneperoxoate

[5,6,7,8-Tetrahydroxy-8-(hydroxymethyl)-2-oxo-1,3,9-trioxa-2lambda5-phosphaspiro[3.5]nonan-2-yl] 2-oxopropaneperoxoate

C9H13O13P (360.00937780000004)


   

3-(4-Bromophenyl)-5-(3,5-dimethoxyphenyl)-1,2,4-oxadiazole

3-(4-Bromophenyl)-5-(3,5-dimethoxyphenyl)-1,2,4-oxadiazole

C16H13BrN2O3 (360.01094880000005)


   

2-(ethylthio)-4-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazol-5(4H)-one

2-(ethylthio)-4-{[5-(2-nitrophenyl)-2-furyl]methylene}-1,3-thiazol-5(4H)-one

C16H12N2O4S2 (360.0238472)


   

2-[[5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid butyl ester

2-[[5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid butyl ester

C14H14Cl2N2O3S (360.0102154)


   

(2R)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate

(2R)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate

C15H10ClF3NO4- (360.02504260000006)


   

(2S)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate

(2S)-2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate

C15H10ClF3NO4- (360.02504260000006)


   

7-Iodo-2',3'-dideoxy-7-deazaadenosine

7-Iodo-2',3'-dideoxy-7-deazaadenosine

C11H13IN4O2 (360.0083228)


7-Iodo-2',3'-dideoxy-7-deazaadenosine is a dideoxynucleoside that can be used in DNA synthesis and sequencing reactions[1].

   

SSR180711 (hydrochloride)

SSR180711 (hydrochloride)

C14H18BrClN2O2 (360.0240098)


SSR180711 hydrochloride is an orally active, selective and reversible α7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSR180711 hydrochloride can act on rat α7 n-AChR (Ki=22 nM; IC50=30 nM) and human α7 n-AChR (Ki=14 nM; IC50=18 nM). SSR180711 hydrochloride increases glutamatergic neurotransmission, ACh release and long-term potentiation (LTP) in the hippocampus[1].